Home » Newsletters » BioWorld

BioWorld

June 5, 1997

View Archived Issues

AntiVirals Nets $16M In IPO 25 Percent More Than Projected

NBAC Down To Wire: Reports Indicate Ethics Panel Favors Legislation

Cell Pathways Raises $17M In Private Financing To Advance Development Of FGN-1

Inhibitor Of Proteolytic Enzyme In Green Tea Sets Off Anticancer Drug Discovery

Other News to Note